These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 8738688

  • 1. Malignant hyperthermia (MH) diagnostics: a comparison between the halothane-caffeine- and the ryanodine-contracture-test results in MH susceptible, normal and control muscle.
    Hartung E, Koob M, Anetseder M, Schoemig P, Krauspe R, Hogrefe G, Engelhardt W.
    Acta Anaesthesiol Scand; 1996 Apr; 40(4):437-44. PubMed ID: 8738688
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inositol 1,4,5-trisphosphate synthesis in mononuclear white blood cells of malignant hyperthermia-susceptible and normal human beings, following in vitro exposure to halothane, caffeine and ryanodine.
    Martens U, Krause T, Scholz J, Wappler F, Steinrücke K, am Esch JS.
    Eur J Anaesthesiol; 2000 Jun; 17(6):364-72. PubMed ID: 10928436
    [Abstract] [Full Text] [Related]

  • 6. An analysis of the predictive probability of the in vitro contracture test for determining susceptibility to malignant hyperthermia.
    Hopkins PM, Ellis FR, Halsall PJ, Stewart AD.
    Anesth Analg; 1997 Mar; 84(3):648-56. PubMed ID: 9052318
    [Abstract] [Full Text] [Related]

  • 7. Classification of malignant hyperthermia-equivocal patients by 4-chloro-M-cresol.
    Gilly H, Musat I, Fricker R, Bittner RE, Steinbereithner K, Kress HG.
    Anesth Analg; 1997 Jul; 85(1):149-54. PubMed ID: 9212139
    [Abstract] [Full Text] [Related]

  • 8. The ryanodine contracture test may help diagnose susceptibility to malignant hyperthermia.
    Reuter DA, Anetseder M, Müller R, Roewer N, Hartung EJ.
    Can J Anaesth; 2003 Jul; 50(7):643-8. PubMed ID: 12944436
    [Abstract] [Full Text] [Related]

  • 9. C1840-T mutation in the human skeletal muscle ryanodine receptor gene: frequency in northern German families susceptible to malignant hyperthermia and the relationship to in vitro contracture response.
    Steinfath M, Singh S, Scholz J, Becker K, Lenzen C, Wappler F, Köchling A, Roewer N, Schulte am Esch J.
    J Mol Med (Berl); 1995 Jan; 73(1):35-40. PubMed ID: 7633940
    [Abstract] [Full Text] [Related]

  • 10. Effects of the serotonin2 receptor agonist DOI on skeletal muscle specimens from malignant hyperthermia-susceptible patients.
    Wappler F, Roewer N, Köchling A, Scholz J, Löscher W, Steinfath M.
    Anesthesiology; 1996 Jun; 84(6):1280-7. PubMed ID: 8669667
    [Abstract] [Full Text] [Related]

  • 11. [Is a presymptomatic malignant hyperthermia in-vitro diagnosis with 4-chloro-3-ethyl phenol possible? A study using porcine skeletal preparations].
    Gerbershagen MU, Wappler F, Fiege M, Weisshorn R, Kolodzie K, Schulte am Esch J.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Feb; 39(2):81-6. PubMed ID: 14767797
    [Abstract] [Full Text] [Related]

  • 12. [4-chloro-m-cresol-induced contractures of skeletal muscle specimen from patients at risk for malignant hyperthermia].
    Wappler F, Scholz J, von Richthofen V, Fiege M, Steinfath M, Schulte am Esch J.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Sep; 32(9):541-8. PubMed ID: 9417254
    [Abstract] [Full Text] [Related]

  • 13. In vitro diagnosis of malignant hyperthermia susceptibility with ryanodine-induced contractures in human skeletal muscles.
    Wappler F, Roewer N, Köchling A, Scholz J, Steinfath M, Schulte am Esch J.
    Anesth Analg; 1996 Jun; 82(6):1230-6. PubMed ID: 8638796
    [Abstract] [Full Text] [Related]

  • 14. 4-Chloro-m-cresol test--a possible supplementary test for diagnosis of malignant hyperthermia susceptibility.
    Ording H, Glahn K, Gardi T, Fagerlund T, Bendixen D.
    Acta Anaesthesiol Scand; 1997 Sep; 41(8):967-72. PubMed ID: 9311392
    [Abstract] [Full Text] [Related]

  • 15. Results of contracture tests with halothane, caffeine, and ryanodine depend on different malignant hyperthermia-associated ryanodine receptor gene mutations.
    Fiege M, Wappler F, Weisshorn R, Ulrich Gerbershagen M, Steinfath M, Schulte Am Esch J.
    Anesthesiology; 2002 Aug; 97(2):345-50. PubMed ID: 12151923
    [Abstract] [Full Text] [Related]

  • 16. [Effects of serotonin 2 receptor agonists on skeletal muscle preparations in patients with a disposition toward malignant hyperthermia].
    Wappler F, Roewer N, Köchling A, Scholz J, Steinfath M, Rumberger E, Löscher W, Schulte am Esch J.
    Anaesthesist; 1995 Aug; 44(8):538-44. PubMed ID: 7573901
    [Abstract] [Full Text] [Related]

  • 17. Similar susceptibility to halothane, caffeine and ryanodine in vitro reflects pharmacogenetic variability of malignant hyperthermia.
    Ginz HF, Girard T, Censier K, Urwyler A.
    Eur J Anaesthesiol; 2004 Feb; 21(2):151-7. PubMed ID: 14977348
    [Abstract] [Full Text] [Related]

  • 18. [Diagnosis of susceptibility to malignant hyperthermia with an in vitro contracture test with the phosphodiesterase iii inhibitor enoximone].
    Fiege M, Wappler F, Scholz J, von Richthofen V, Brinken B, Schulte am Esch J.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Sep; 33(9):557-63. PubMed ID: 9787864
    [Abstract] [Full Text] [Related]

  • 19. High-purity ryanodine and 9,21-dehydroryanodine for in vitro diagnosis of malignant hyperthermia in man.
    Wappler F, Roewer N, Lenzen C, Köchling A, Scholz J, Steinfath M, Schulte am Esch J.
    Br J Anaesth; 1994 Feb; 72(2):240-2. PubMed ID: 8110584
    [Abstract] [Full Text] [Related]

  • 20. [Diagnosis of malignant hyperthermia susceptibility. 1. The significance of in vitro susceptibility tests].
    Mortier W, Breucking E.
    Anaesthesist; 1993 Oct; 42(10):675-83. PubMed ID: 8250201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.